Chimovits Erez
SEC CIK 1706399 · EDGAR
BoughtSold
Most active insiders at BRVE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Forbion Growth Opportunities Fund III Cooperatief U.A. | 10% | $64.80M | — |
| 2 | Chimovits Erez | Dir, 10% | $34.92M | — |
| 3 | ORBIMED ADVISORS LLC | Dir, 10% | $34.92M | — |
| 4 | AH Bio Fund IV, L.P. | 10% | $19.80M | — |
| 5 | Murdoch Travis | CEO, Pres, Dir | $1.50M | — |
| 6 | Viehbacher Christopher | Dir | $1.50M | — |
| 7 | Lubner David Charles | Dir | $1000.0K | — |
| 8 | Rickey James Paul | CFO | $500.0K | — |
| 9 | Malek David I | Dir | $75.0K | — |
| 10 | Anderson Michele A. | Chief Development Off | $20.0K | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2026-08-11 17:31 | 2026-08-07 | BRVE | Braveheart Bio, Inc. | Chimovits Erez | Dir, 10% | C - Cnv Deriv | — | +9.13M | 10.24M | +828% | — |
| DMI | 2026-08-11 17:31 | 2026-08-07 | BRVE | Braveheart Bio, Inc. | Chimovits Erez | Dir, 10% | P - Purchase | $18.00 | +1.94M | 273.3K | New | +$34.92M |
| DMI | 2024-10-17 | 2024-10-15 | UPB | Upstream Bio, Inc. | Chimovits Erez | Dir, 10% | C - Cnv Deriv | — | +3.61M | 3.89M | +1,266% | — |
| DMI | 2024-10-17 | 2024-10-15 | UPB | Upstream Bio, Inc. | Chimovits Erez | Dir, 10% | P - Purchase | $17.00 | +825.0K | 4.55M | +22% | +$14.03M |
Purchase Sale Sale after option exercise All abbreviations